126 related articles for article (PubMed ID: 25389240)
1. Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma.
Yorukoglu A; Yalcin N; Avci A; Cakalagaoglu F; Yaylali G; Akin F; Haciyanli M; Ozden A
Int J Surg Pathol; 2015 Feb; 23(1):5-12. PubMed ID: 25389240
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
Tong J; Wang Y; Da JP
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
[TBL] [Abstract][Full Text] [Related]
3. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
Aiad HA; Bashandy MA; Abdou AG; Zahran AA
Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
[TBL] [Abstract][Full Text] [Related]
4. Role of Ki-67 as a proliferative marker in lesions of thyroid.
Pujani M; Arora B; Pujani M; Singh SK; Tejwani N
Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.
Song Q; Wang D; Lou Y; Li C; Fang C; He X; Li J
Diagn Pathol; 2011 Dec; 6():126. PubMed ID: 22188859
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
Abouhashem NS; Talaat SM
Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
[TBL] [Abstract][Full Text] [Related]
7. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
[TBL] [Abstract][Full Text] [Related]
8. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions.
Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G
Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088
[TBL] [Abstract][Full Text] [Related]
9. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of the gap junction protein connexin43 is associated with papillary thyroid carcinomas when compared with other noncancer pathologies of the thyroid.
Dominguez C; Karayan-Tapon L; Desurmont T; Gibelin H; Crespin S; Fromont G; Levillain P; Bouche G; Cantereau A; Mesnil M; Kraimps JL
Thyroid; 2011 Oct; 21(10):1057-66. PubMed ID: 21875346
[TBL] [Abstract][Full Text] [Related]
11. Proliferative activity of papillary carcinoma and benign papillary hyperplasia of thyroid follicular cells.
Dziecioł J; Lemancewicz D; Lebkowska U; Augustynowicz A; Dadan J; Klim B; Małdyk J
Folia Histochem Cytobiol; 2002; 40(2):201-2. PubMed ID: 12056645
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors.
Slosar M; Vohra P; Prasad M; Fischer A; Quinlan R; Khan A
Endocr Pathol; 2009; 20(3):149-57. PubMed ID: 19449140
[TBL] [Abstract][Full Text] [Related]
13. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
[TBL] [Abstract][Full Text] [Related]
14. DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter.
Evren B; Yılmaz S; Karadağ N; Sertkaya AÇ; Topaloğlu Ö; Kılınç F
Sci Rep; 2021 May; 11(1):9932. PubMed ID: 33976347
[TBL] [Abstract][Full Text] [Related]
15. Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases.
Takada N; Hirokawa M; Ito M; Ito A; Suzuki A; Higuchi M; Kuma S; Hayashi T; Kishikawa M; Horikawa S; Miyauchi A
Endocr J; 2017 Oct; 64(10):1017-1023. PubMed ID: 28794344
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
Pyo JS; Kim DH; Yang J
Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
[TBL] [Abstract][Full Text] [Related]
17. Value of immunoperoxidase staining of thyroglobulin in fine needle aspiration cytology of thyroid diseases.
Tung CC; Chang TC; Hsieh HC
Acta Cytol; 1995; 39(3):396-401. PubMed ID: 7539201
[TBL] [Abstract][Full Text] [Related]
18. Can CD10 be used as a diagnostic marker in thyroid pathology?
Yegen G; Demir MA; Ertan Y; Nalbant OA; Tunçyürek M
Virchows Arch; 2009 Jan; 454(1):101-5. PubMed ID: 19031085
[TBL] [Abstract][Full Text] [Related]
19. Expression of ki67 in papillary thyroid microcarcinoma and its clinical significance.
Zhou Y; Jiang HG; Lu N; Lu BH; Chen ZH
Asian Pac J Cancer Prev; 2015; 16(4):1605-8. PubMed ID: 25743839
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
